Lusvertikimab (OSE-127) is a humanized IL7R monoclonal antibody. Lusvertikimab is not internalized by target cells and prevents IL7R heterodimerization and subsequent downstream signaling. Lusvertikimab has anti-leukemic efficacy and has the potential for B cell precursor acute lymphoblastic leukemia (BCP-ALL) research.
Purity:
>98.0%
CAS Number:
[2375835-91-7]
Target:
IL Receptor/Related
* VAT and and shipping costs not included. Errors and price changes excepted